How it went
Did it last?
- 4 of 5 said the benefit wore off: the 4 who relapsed.
- 1 of 5 needed to keep doing it to stay well.
Read from what people wrote. A story that ends without a follow-up counts as lasting, so treat these as minimums.
| Outcome described | Accounts | Share |
|---|---|---|
| Full recovery | 1 | 20% |
| Near-full | 0 | 0% |
| Substantial | 0 | 0% |
| Partial | 0 | 0% |
| Relapsed | 4 | 80% |
| No benefit | 0 | 0% |
Only 5 accounts. Treat these percentages as anecdotes, not rates.
By how ill people were
| Severity at worst | How it went | n | Recovered |
|---|---|---|---|
| Severe | 2 | 50% |
3 accounts don’t say how ill the person was.
Who published these accounts
Right-hand number: share describing a full or near-full recovery. Pages that sell something, and advocacy sites, tend to publish only the successes.
All 5 accounts
-
I'm normal now. Here's my promised update for y'all
Started with IFN lambda combined with GS-441524 for underlying Enterovirus B infections, which brought about 60% improvement, then moved to a multi-drug antiviral regimen described as molnupiravir, GS-441524, Vermurafenib, ribavirin and pleconaril plus…
-
Dr Chia finds enterovirus patients given remdesivir remain in remission (Godlovesatrier)
A long COVID patient who took a five-day molnupiravir course and experienced roughly four months of what he calls an almost near remission afterwards. It was not permanent: by the time of posting he was planning a second course and looking into remdesivir…
-
Dr Chia finds enterovirus ME/CFS patients given remdesivir remain in remission (Teodora)
A long COVID patient with associated enterovirus involvement. A Paxlovid course produced remarkable reductions in pain and improved energy, but stopping it triggered a horrendous symptomatic rebound. A later molnupiravir course gave only modest benefit by…
-
HHV-6/EBV testing UK? / Remitting symptoms on Molnupiravir?
Replying to FoxgloveFever's molnupiravir account, writes "just an FYI this happened to me on molnu too - at least I experienced 90% for four months and then relapsed." Gives no detail on the molnupiravir dose or course, or on illness duration or severity…
-
HHV-6/EBV testing UK? / Remitting symptoms on Molnupiravir?
Took a standard course of molnupiravir to treat a COVID infection in 2023, against a backdrop of ME/CFS since 2006 (severity "varying from mild to severe") plus Long Covid from 2022 that had left her "mostly bedbound for a year." Reports "my ME/CFS symptoms…